BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 28396119)

  • 1. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
    Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
    Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.
    Lugthart G; Melsen JE; Vervat C; van Ostaijen-Ten Dam MM; Corver WE; Roelen DL; van Bergen J; van Tol MJ; Lankester AC; Schilham MW
    J Immunol; 2016 Jul; 197(1):78-84. PubMed ID: 27226093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector γδ T cells in human renal fibrosis and chronic kidney disease.
    Law BM; Wilkinson R; Wang X; Kildey K; Lindner M; Beagley K; Healy H; Kassianos AJ
    Nephrol Dial Transplant; 2019 Jan; 34(1):40-48. PubMed ID: 29897565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
    Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired natural killer cell subset phenotypes in human obesity.
    Bähr I; Jahn J; Zipprich A; Pahlow I; Spielmann J; Kielstein H
    Immunol Res; 2018 Apr; 66(2):234-244. PubMed ID: 29560551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
    Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
    Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
    Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
    Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.
    Lin AW; Gonzalez SA; Cunningham-Rundles S; Dorante G; Marshall S; Tignor A; Ha C; Jacobson IM; Talal AH
    Clin Exp Immunol; 2004 Aug; 137(2):408-16. PubMed ID: 15270860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
    Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
    J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
    J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.
    Kassianos AJ; Wang X; Sampangi S; Muczynski K; Healy H; Wilkinson R
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1391-401. PubMed ID: 24049150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection.
    Kildey K; Francis RS; Hultin S; Harfield M; Giuliani K; Law BMP; Wang X; See EJ; John G; Ungerer J; Wilkinson R; Kassianos AJ; Healy H
    Front Immunol; 2019; 10():1877. PubMed ID: 31440252
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis.
    Scrivo R; Peruzzi G; Gattamelata A; Gross CC; Carletti R; Di Gioia C; Brandt J; Priori R; Morrone S; Santoni A; Valesini G
    Cytometry B Clin Cytom; 2018 May; 94(3):412-422. PubMed ID: 28834234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Tissue-Resident Mucosal-Associated Invariant T (MAIT) Cells in Renal Fibrosis and CKD.
    Law BMP; Wilkinson R; Wang X; Kildey K; Giuliani K; Beagley KW; Ungerer J; Healy H; Kassianos AJ
    J Am Soc Nephrol; 2019 Jul; 30(7):1322-1335. PubMed ID: 31186283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.